choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

News and Updates

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

oncNGS PCP - European Call for tender for the future Next Generation Sequencing (NGS) solutions for cancer

Published on | 1 month ago

Programmes Health  

The aim of the oncNGS pre-commercial procurement (PCP) is to develop affordable integrated solutions that can completely transform cancer patients' experience through predictive diagnosis, prognosis and theranosis capabilities based on Next Generation Sequencing (NGS) technology. OncNGS invites entrepreneurs, start-ups, companies, academia, and other relevant stakeholders to present their proposal for designing, developing and testing their solution that will be provided during this PCP.

The oncNGS PCP Call for tender is now open. Deadline for submission is 17 October 2022.

  • The contract notice of the Pre-commercial procurement has been published at Tenders Electronic Daily here.
  • The complete tender documentation is available here.
  • Bidders can participate in a joint tender and look for suitable partners through oncNGS' matchmaking page.
  • A Frequently Asked Questions page is also available on the oncNGS website.

All detailed information can be found on oncNGS' website.


Background information: The Horizon 2020 financed project 'OncNGS'  is a strong consortium composed of 8 buyers from 5 EU Member States (Sciensano ; Institut Jules Bordet (Belgium) ; Institut Curie ; Hospices Civils de Lyon (France) ; Charite Universitaetsmedizin ; Ludwig Maximilians Universitaet Muenchen (Germany) ; Alleanza Contro il Cancro (Italy) ; Institut Catala d’Oncologia (Spain)) and supported by 6 entities with wide experience in their fields (Agència de Qualitat i Avaluació Sanitàries de Catalunya ; the Belgian Cancer Registry ; Institut National du Cancer ; Instituto de Investigación Biomédica de Salamanca ; Valle de Hebrón Instituto de Oncología ; De Clercq & Partners). 


- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

845 articles available search in articles 


image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.


Read the full article for details  or Check out the other testimonials